Validation of the FRAX predictive model for major osteoporotic fracture in a historical cohort of spanish women

Journal of Clinical Densitometry

Volumn 16, Issue 2, 2013, Pages 231-237

  Tebé Cordomí, Cristian ^a,b   del Río, Luís Miguel ^c,d   Di Gregorio, Silvana ^b,d   Casas, Lidia ^b,e,f   Estrada, Maria Dolors ^a,b   Kotzeva, Anna ^a,b   Espallargues, Mireia ^a,b  

^a Avaluació i Qualitat en Salut ^*  (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c CETIR Grup Medic   (Spain)

^d Red de Envejecimiento del Carlos III   (Spain)

^e CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^f HOSPITAL DEL MAR   (Spain)

Author keywords

Bone mineral density; Cohort studies; FRAX; Major osteoporotic fracture; Osteoporosis

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; CALCULATION; CALIBRATION; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; FEMALE; FOREARM FRACTURE; FRAGILITY FRACTURE; FRAX TOOL; HIP FRACTURE; HUMAN; HUMERUS FRACTURE; INCIDENCE; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SPAIN; SPINE FRACTURE; VALIDATION STUDY;

ADULT; AGED; AREA UNDER CURVE; BONE DENSITY; FEMALE; HIP FRACTURES; HUMANS; MIDDLE AGED; OSTEOPOROTIC FRACTURES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SPAIN; SPINAL FRACTURES;

EID: 84877065591     PISSN: 10946950     EISSN: 15590747     Source Type: Journal    
DOI: 10.1016/j.jocd.2012.05.007     Document Type: Article

References (28)

1. Kanis J.A., Johnell O., Oden A., et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008, 19(4):385-397.
2. Reeve J., Silman A. Epidemiology of osteoporotic fractures in Europe: towards biologic mechanisms. The European Prospective Osteoporosis Study Group. Osteoporos Int 1997, 7(3):78-83. EPOS Study Group.
3. O'Neill T.W., Marsden D., Matthis C., et al. Survey response rates: national and regional differences in a European multicentre study of vertebral osteoporosis. J Epidemiol Community Health 1995, 49(1):87-93.
4. Kanis J.A., Oden A., Johnell O., et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007, 18(8):1033-1046.
5. Azagra R., Roca G., Encabo G., et al. Prediction of absolute risk of fragility fracture at 10 years in a Spanish population: validation of the WHO FRAX tool in Spain. BMC Musculoskelet Disord 2011, 12:30.
6. Alvarez-Nebreda M.L., Jiménez A.B., Rodríguez P., Serra J.A. Epidemiology of hip fracture in the elderly in Spain. Bone 2008, 42(2):278-285.
7. Elffors I., Allander E., Kanis J.A., et al. The variable incidence of hip fracture in southern Europe: the MEDOS Study. Osteoporos Int 1994, 4(5):253-263.
8. Cummings S.R., Melton L.J. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002, 359(9319):1761-1767.
9. Ettinger B., Black D.M., wson-Hughes B., et al. Updated fracture incidence rates for the US version of FRAX. Osteoporos Int 2010, 21(1):25-33.
10. González-Macías J., Marín F., Vila J., et al. Prevalencia de factores de riesgo de osteoporosis y fracturas osteoporóticas en una serie de 5.195 mujeres mayores de 65 años. [Risk factors for osteoporosis and osteoporotic fractures in a series of 5,195 women older than 65 years]. [Article in Spanish]. Med Clin (Barc) 2004, 123(3):85-89.
11. Kanterewicz E., Puigoriol E., Peris P., et al. Relación del telopéptido carboxiterminal del colágeno tipo I sérico con la densidad mineral ósea y el consumo de fármacos en mujeres posmenopáusicas. Datos preliminares del estudio FRODOS. [Relationship between C-telopeptides of type I collagen serum values with bone mineral density and antiosteoporotic drug intake in postmenopausal women. Preliminary data from the FRODOS study]. [Article in Spanish]. Med Clin (Barc) 2009, 133(16):609-614.
12. Sanfélix-Genovés J., Peiró S., Sanfélix-Gimeno G., et al. Development and validation of a population-based prediction scale for osteoporotic fracture in the region of Valencia, Spain: the ESOSVAL-R study. BMC Public Health 2010, 10:153.
13. González-Macías J., Marin F., Vila J., Díez-Pérez A. Probability of fractures predicted by FRAX and observed incidence in the Spanish ECOSAP study cohort. Bone 2011, 50:373-377.
14. Tebé C., Casas L., Del Rio L., et al. Factores de riesgo de fracturas por fragilidad en una cohorte de mujeres españolas. [Risk factors for fragility fractures in a cohort of Spanish women.] [Article in Spanish]. Gac Sanit 2011, 25(6):507-512.
15. Musgrave K.O., Giambalvo L., Leclerc H.L., et al. Validation of a quantitative food frequency questionnaire for rapid assessment of dietary calcium intake. J Am Diet Assoc 1989, 89(10):1484-1488.
16. Kanis J.A., Oden A., Johnell O., et al. The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 2001, 12(5):417-427.
17. Azagra R., Roca G., Zwart M., Encabo G. Med Clin (Barc) 2011, 137(15):713-714. [Article in Spanish].
18. Ensrud K.E., Lui L.Y., Taylor B.C., et al. A comparison of prediction models for fractures in older women: is more better?. Arch Intern Med 2009, 169(22):2087-2094.
19. Sandhu S.K., Nguyen N.D., Center J.R., et al. Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram. Osteoporos Int 2010, 21(5):863-871.
20. Ismail A.A., O'Neill T.W., Cockerill W., et al. Validity of self-report of fractures: results from a prospective study in men and women across Europe. EPOS Study Group. European Prospective Osteoporosis Study Group. Osteoporos Int 2000, 11(3):248-254.
21. Honkanen K., Honkanen R., Heikkinen L., et al. Validity of self-reports of fractures in perimenopausal women. Am J Epidemiol 1999, 150(5):511-516.
22. Chen Z., Kooperberg C., Pettinger M., et al. Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the women's health initiative observational study and clinical trials. Menopause 2004, 11(3):264-274.
23. Tebé C., Espallargues M., Estrada M., et al. Análisis de los factores de riesgo y la probabilidad de fractura por fragilidad en una cohorte de mujeres con indicación de densitometría ósea. [Risk factor analysis and probability of fragility fracture in a cohort of women with bone densitometry indication]. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad y Política Social 2010, Ministerio de Ciencia e Innovación. Agència d'Informació, Avaluació i Qualitat en Salut de Cataluña, Informes de Evaluación de Tecnologías Sanitarias, AATRM núm. 2009/04.
24. Bentler S.E., Liu L., Obrizan M., et al. The aftermath of hip fracture: discharge placement, functional status change, and mortality. Am J Epidemiol 2009, 170(10):1290-1299.
25. Roig Vilaseca D., Gómez Vaquero C., Hoces Otero C., Nolla J.M. Riesgo de fractura calculado con el índice FRAX en pacientes con osteoporosis tratados y no tratados. [Fracture risk calculated with the FRAX index in patients with osteoporosis treated and untreated]. [Article in Spanish]. Med Clin (Barc) 2010, 134:189-193.
26. Gómez-Navarro R. Aplicación de la herramienta FRAX(R) para la determinación del riesgo de fractura en mujeres de un ámbito rural. [Use of the FRAX algorithm to calculate the fracture risk in women of a rural area]. [Article in Spanish]. Rev Esp Salud Publica 2010, 84(3):321-330.
27. Naranjo A., Ojeda-Bruno S., Francisco-Hernández F., et al. Aplicación de las guías clínicas de prevención secundaria de fractura osteoporótica y del índice FRAX en una cohorte de pacientes con fractura por fragilidad. [Application of guidelines for secondary prevention of fracture and the FRAX index in patients with fragility fracture]. [Article in Spanish]. Med Clin (Barc) 2011, 136:290-292.
28. Díez-Pérez A. El debate sobre la escala FRAX. [The FRAX tool debate]. [Article in Spanish]. Rev Osteoporos Metab Miner 2010, 1:5-6.